Simbrad
25 May 2016
Read Arden Partners's note on SCAPA GROUP PLC (SCPA), out this morning on Research Tree: "Finals reflected good underlying progress across both the Healthcare and Industrial divisions as well as a full year contribution from First Water, which was acquired in February 2015. Revenues increased 4.5% to £246.7m, (+4.1% constant FX) and with the trading margin improving from 7.9% to 8.6%, trading profits grew 14.5% to £21.3m (+14.5% constant FX). Adjusted PBT (excluding pension costs and exceptionals) was up 15.1% to £20.6m and adjusted EPS grew 16.5% to 10.6p, helped by a slight reduction in the tax rate..."
II Editor
24 May 2016
NEW ARTICLE: Soaring Scapa still well-backed " Last year's decision to shut its Swiss factory and move business to France distorted LSE:SCPA:Scapa's reported 12-month results. Strip out £5.1 million of associated costs, however, and trading profit at the tapes and adhesives firm grew by more ..."[link]
oldjoe1
15 Apr 2016
SCPA...Big Potential......... Scapa Group plc 27.1% Potential Upside Indicated by BerenbergPosted by: Katherine Hargreaves 15th April 2016Scapa Group plc using EPIC/TICKER code LON:SCPA has had its stock rating noted as ‘Retains’ with the recommendation being set at ‘BUY’ this morning by analysts at Berenberg. Scapa Group plc are listed in the Basic Materials sector within AIM. Berenberg have set their target price at 300 GBX on its stock. This is indicating the analyst believes there is a potential upside of 27.1% from the opening price of 236 GBX. Over the last 30 and 90 trading days the company share price has increased 31.2933 points and increased 49 points respectively. Scapa Group plc LON:SCPA has a 50 day moving average of 204.10 GBX and a 200 day moving average of 202.42 GBX. The 1 year high share price is 245 GBX while the 52 week low is 156.73 GBX. There are currently 150,942,761 shares in issue with the average daily volume traded being 361,839. Market capitalisation for LON:SCPA is £363,394,697 GBP.
oldjoe1
15 Apr 2016
SCPA........UPGRADE SCPA SCAPA Group PLCBerenberg note this morning was in fact an upgrade in the SP, details below....08:10 Broker Forecast - Berenberg issues a broker note on Scapa Group PLCBerenberg today reaffirms its buy investment rating on Scapa Group PLC (LON:SCPA) and raised its price target to 300p (from 260p). Story provided by StockMarketWire.com
oldjoe1
15 Apr 2016
SCPA.....Broker Updates...... SCPA SCAPA GroupA number of Broker updates out yesterday, IMO they are holding back while the results next month before revising earnings upwards..........Numis Securities Ltd 14-04-16 ADD 20.60 10.60 2.10 23.30 12.00 2.60Cantor Fitzgerald Europe 14-04-16 HOLD 19.80 9.70 2.00 22.20 10.90 2.30Arden Partners 14-04-16 ADD 19.40 9.88 2.00 22.40 11.41 2.60N+1 Singer 14-04-16 CORP 20.60 10.20 2.00 21.68 10.60 2.30
oldjoe1
15 Apr 2016
SCPA, Broker BUY Update......... SCPA Scapa Group broker Buy out......Scapa Group PLC SCPA Berenberg Buy 242.75 242.75 260.00 300.00 RetainsSP Target 300p
oldjoe1
14 Apr 2016
Re: SCPA, AHEAD OF EXPECTATIONS........ [link]
oldjoe1
14 Apr 2016
Re: SCPA, AHEAD OF EXPECTATIONS........ Try that chart again showing the gap up........[link]
oldjoe1
14 Apr 2016
Re: SCPA, AHEAD OF EXPECTATIONS........ CEO comment......CEO comment.......Heejae Chae, CEO commented:"We have delivered another set of strong results which are ahead of expectations as we execute our strategies for Healthcare and Industrial. Notwithstanding challenging global market conditions, we remain confident of achieving further progress through organic growth and acquisitions."Scapa expects to report its full year results on 24 May 2016.
oldjoe1
14 Apr 2016
SCPA, AHEAD OF EXPECTATIONS........ SCPA Scapa Groupfantastic results......[link] revenue is ahead of last year and Group trading profits* and margins are both ahead of last year and expectations".[link]
mcescher
28 Mar 2016
Thoughts on Scapa Group The EPS growth is expected to be 45%. ([link] Anyone believe the analysts?
jezza51
24 Nov 2015
Interims not much wrong with the results - business continues with self help in industrial and building on the higher margin medical. think an interim dividend would have helped to reinforce a positive message - but the company can use the cash more effectively than paying dividends. The rating is demanding and doesn't give any room for mistakes; they will be making more acquisitions and they have shown they can manage these well. Target price 230 next year and 270 in 2017. If the market can't see the positives - look to buy on weakness down to 170
sootmeistre
18 Jul 2015
2 late trades for 1 mil+shares? 16:34:51 216.43p 809,911 £1,752,890 ? O16:30:30 216p 290,284 £627,013 total 1,100,195Anybody any thoughts??Average vol according to yahoo 322,803'Things that make you go Hmmm'
wineberry
25 Jan 2015
Tipped One of Momentum Investor's naps for 2015 - not that there record in 2014 was all that brilliant!
jezza51
04 Jan 2015
Good value Schroder stake is now below 10% and is being picked up by Blackrock. Once this overhang is out of the way which may take a couple of months can see this moving towards 150p. Currency effects of euro should be more than offset with $ exposure. Raw material costs should be reducing. Expect another acquisition this year - this may pause any advance but the management will not proceed unless the price is attractive. Solid hold and buy on any weakness.
